TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 101 filers reported holding TG THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $675 | +57.3% | 24,476 | +41.9% | 0.00% | 0.0% |
| Q2 2023 | $429 | +65.6% | 17,253 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $259 | +27.0% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $204 | -99.8% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $102,000 | +39.7% | 17,253 | 0.0% | 0.00% | – |
| Q2 2022 | $73,000 | -55.5% | 17,253 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $164,000 | -50.0% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $328,000 | -42.9% | 17,253 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $574,000 | -14.2% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $669,000 | -19.6% | 17,253 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $832,000 | -7.3% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $898,000 | +94.4% | 17,253 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $462,000 | +37.5% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $336,000 | +93.1% | 17,253 | -2.4% | 0.00% | +100.0% |
| Q1 2020 | $174,000 | +17.6% | 17,680 | +32.4% | 0.00% | 0.0% |
| Q4 2019 | $148,000 | +97.3% | 13,349 | 0.0% | 0.00% | – |
| Q3 2019 | $75,000 | -34.8% | 13,349 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $115,000 | +7.5% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $107,000 | +94.5% | 13,349 | 0.0% | 0.00% | – |
| Q4 2018 | $55,000 | -26.7% | 13,349 | 0.0% | 0.00% | – |
| Q3 2018 | $75,000 | -57.4% | 13,349 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $176,000 | -7.4% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $190,000 | +74.3% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $109,000 | -31.0% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $158,000 | +17.9% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $134,000 | -14.1% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $156,000 | +151.6% | 13,349 | 0.0% | 0.00% | – |
| Q4 2016 | $62,000 | -39.8% | 13,349 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $103,000 | +27.2% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $81,000 | -28.9% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $114,000 | +5.6% | 13,349 | +46.9% | 0.00% | 0.0% |
| Q4 2015 | $108,000 | +17.4% | 9,090 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $92,000 | -39.1% | 9,090 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $151,000 | – | 9,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
| RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
| KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
| Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
| Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
| Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
| MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
| SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
| 683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |